Schedule 13G ownership disclosure

CS DIAGNOSTICS CORP.

Common Stock (CUSIP 33852L202) and Series B Preferred Stock (no CUSIP assigned) · CUSIP: 33852L202

Event date: 2025-09-30

Filing-level shares
13,392,434.00
Percent of class
9.9%
  • Graus Thomas

    Shares: 13,392,434.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002082730-25-000001
Form type
SCHEDULE 13G
Filer
CS DIAGNOSTICS CORP.
CIK
CIK 1106861
Filed
Oct 06, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub